Aggressive combination chemotherapy in multiple myeloma. A multicentre trial

This publication has 10 references indexed in Scilit:

• Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma
  Blood, 1984
• Treatment of multiple myeloma with M-2 protocol and without maintenance therapy
  European Journal of Cancer and Clinical Oncology, 1983
• HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA
  The Lancet, 1983
• The Current Status and Future Prospects of Treatment for Multiple Myeloma
  Clinics in Haematology, 1982
• Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma
  Blood, 1980
• The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia
  New England Journal of Medicine, 1979
• Improved survival of increased-risk myeloma patients on combined triple- alkylating-agent therapy: a study of the CALGB
  Blood, 1979
• Unmaintained remissions in multiple myeloma
  Blood, 1978
• Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol
  The American Journal of Medicine, 1977
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
  Cancer, 1975